百惠778899
2021-09-20
钟南山钟老所牵头所中意的腾盛博药-一定是能造福于人类的一流科研机构!期待!
@腾盛博药2137HK:
SVB Leerink 将 腾盛博药-B(02137.HK) 目标价提高至55.00元
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":860059624,"tweetId":"860059624","gmtCreate":1632110156168,"gmtModify":1632114454629,"author":{"id":3585548756248504,"idStr":"3585548756248504","authorId":3585548756248504,"authorIdStr":"3585548756248504","name":"百惠778899","avatar":"https://static.tigerbbs.com/2e6a5f6bb5a1e844bff5ad96d4e2f085","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>钟南山钟老所牵头所中意的腾盛博药-一定是能造福于人类的一流科研机构!期待!</p></body></html>","htmlText":"<html><head></head><body><p>钟南山钟老所牵头所中意的腾盛博药-一定是能造福于人类的一流科研机构!期待!</p></body></html>","text":"钟南山钟老所牵头所中意的腾盛博药-一定是能造福于人类的一流科研机构!期待!","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/860059624","repostId":810899705,"repostType":1,"repost":{"magic":2,"id":810899705,"tweetId":"810899705","gmtCreate":1629959468707,"gmtModify":1629961234330,"author":{"id":4088222930030430,"idStr":"4088222930030430","authorId":4088222930030430,"authorIdStr":"4088222930030430","name":"腾盛博药2137HK","avatar":"https://static.tigerbbs.com/7225daebeee9c083bcbed970259d2446","vip":5,"userType":5,"introduction":"致力于服务患者需求,提升中国公共医疗保健水平","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4663,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/3658b9d8400878741eaebd84aac45e30"}],"coverImages":[{"img":"https://static.tigerbbs.com/3658b9d8400878741eaebd84aac45e30"}],"title":"SVB Leerink 将 腾盛博药-B(02137.HK) 目标价提高至55.00元","extraTitle":"","html":"<html><head></head><body><p>SVB Leerink发表研究报告,提高<a target=\"_blank\" href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a> 目标价至55.00元每股,指出公司关于新冠中和抗体的积极数据,期待下一步的紧急使用授权申请和销售预期。(公司专注於研发乙型肝炎病毒、HIV、细菌感染、新冠病毒等重大传染病的创新疗法,目前产品线有逾10个项目。)</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3658b9d8400878741eaebd84aac45e30\"></p><p>SVB Leerink表示,继续持续看好公司新冠中和抗体项目和自主研发。虽然早期自主研发项目仍处于临床一期阶段,但腾盛博药有不少项目具有发展为「同类第一」(First-in-class)的潜力,给予目标价55.00元。</p></body></html>","htmlText":"<html><head></head><body><p>SVB Leerink发表研究报告,提高<a target=\"_blank\" href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a> 目标价至55.00元每股,指出公司关于新冠中和抗体的积极数据,期待下一步的紧急使用授权申请和销售预期。(公司专注於研发乙型肝炎病毒、HIV、细菌感染、新冠病毒等重大传染病的创新疗法,目前产品线有逾10个项目。)</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3658b9d8400878741eaebd84aac45e30\"></p><p>SVB Leerink表示,继续持续看好公司新冠中和抗体项目和自主研发。虽然早期自主研发项目仍处于临床一期阶段,但腾盛博药有不少项目具有发展为「同类第一」(First-in-class)的潜力,给予目标价55.00元。</p></body></html>","text":"SVB Leerink发表研究报告,提高$腾盛博药-B(02137)$ 目标价至55.00元每股,指出公司关于新冠中和抗体的积极数据,期待下一步的紧急使用授权申请和销售预期。(公司专注於研发乙型肝炎病毒、HIV、细菌感染、新冠病毒等重大传染病的创新疗法,目前产品线有逾10个项目。) SVB Leerink表示,继续持续看好公司新冠中和抗体项目和自主研发。虽然早期自主研发项目仍处于临床一期阶段,但腾盛博药有不少项目具有发展为「同类第一」(First-in-class)的潜力,给予目标价55.00元。","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/810899705","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["02137"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":414,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":976,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02137"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":71,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/860059624"}
精彩评论